Work

Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe

Year: 2017

Type: article

Source: Diagnostic Microbiology and Infectious Disease

DOI: 10.1016/j.diagmicrobio.2017.12.001

Authors: David B. Huang, Thomas M. File, Matthew Dryden, G. Ralph Corey, Antoni Torres, Mark H Wilcox

Institutions: Motif BioSciences (United States), Rutgers New Jersey Medical School, Summa Health System, Hampshire Hospitals NHS Foundation Trust, Duke Medical Center, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Centro de Investigación Biomédica en Red, Hospital Clínic de Barcelona, Universitat de Barcelona, University of Leeds, Leeds Teaching Hospitals NHS Trust

Language: English

Topic: Antimicrobial Resistance in Staphylococcus

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Gilead Sciences, Medicines Company, Nabriva Therapeutics

OpenAlex ID: W2775563532

FWCI: 3.158

Cites: 9

Cited by: 18

Related to: 10